Trial: anti-PD1 and anti-KIR combined

Alexandra
Alexandra Member Posts: 1,308
in Ovarian Cancer #1

IS ANYONE PARTICIPATING IN THIS TRIAL?

This trial sounds very promising. It combines two experimental drugs, the much-sought-after PD-1 drug BMS-936558 (nivolumab) and an anti-KIR drug BMS-986015. This trial is available to qualified patients with colorectal cancer, kidney cancer, melanoma, NSCLC (non-small cell lung cancer), and ovarian cancer. The trial is underway in Baltimore, Chicago, and New York.

Note: This trial is not yet recruiting in Boston or Portland.

http://clinicaltrials.gov/show/NCT01714739

 

Comments

  • DaveMcF
    DaveMcF Member Posts: 1
    #2
    Any Luck

    Curious if anyone has particiapted in this trial.  I am just starting my search for a promising trial that includes Anti-PD1.

Discussion Boards